ORYZON Appoints Eisai Executive Vanessa Almendro Navarro to Board of Directors
MADRID, Spain and CAMBRIDGE, Mass., April 17, 2020 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with high unmet medical …